๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Head and Neck Carcinoma

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound NCT07357571n/a2 sites๐Ÿ“ Guangdong๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University "Xijiang Project" Screening Cohort for NPC NCT06787456n/a1 site๐Ÿ“ Zhuhai Ming-Yuan Chen ยท Tests: EBV antibodies test, EBV DNA test, epidemiological information survey, Clinical examinations for high-risk participantsโ€ฆ Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma NCT04448522Phase 36 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Shaoguan Sun Yat-sen University ยท Tests: reduced dosage IMRT, conventional dosage IMRT Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC) NCT07190755NA2 sites๐Ÿ“ Rouen๐Ÿ“ Vandล“uvre-lรจs-Nancy Centre Henri Becquerel ยท Tests: Remote symptoms moniotring Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas NCT04620187Phase 213 sites๐Ÿ“ Atlanta๐Ÿ“ Chicago๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy, Standard of Care Chemotherapy Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma NCT05587543EARLY Phase 11 site๐Ÿ“ Shanghai Fudan University ยท Tests: PK Blood Collection, CAR, TCR An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas NCT07178847NA4 sites๐Ÿ“ Aurillac๐Ÿ“ Clermont-Ferrand๐Ÿ“ Lyon Centre Jean Perrin ยท Tests: blood sampling Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma NCT07125755Phase 37 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Guilin Sun Yat-sen University ยท Tests: Cisplatin EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma NCT06802835Phase 1, Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: EGFR Antibody, PD-1 antibody, Gemcitabine, Cisplatin, IMRT Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663Phase 2, Phase 31 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4 Adebrelimab ยฑInduction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC NCT06510660Phase 21 site๐Ÿ“ Fuzhou Fujian Medical University Union Hospital ยท Tests: adebrelimab Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) NCT06572423NA1 site๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Personalized ultrafractionated stereotactic adaptive radiotherapy, Volume Modulated Arc Therapy, Computed Tomography, Pโ€ฆ Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC. NCT06059261Phase 21 site๐Ÿ“ Chongqing Chongqing University Cancer Hospital ยท Tests: Envafolimab and recombinant human endostatin combined with chemoradiotherapy Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC NCT06657690Phase 21 site๐Ÿ“ Zhuhai Sun Yat-sen University ยท Tests: Irinotecan liposome, S-1 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial NCT05674396Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Stereotactic body radiotherapy, Traditional Palliation A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Birmingham Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046054, pembrolizumab A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma NCT06976190Phase 31 site๐Ÿ“ Guangzhou Lepu Biopharma Co., Ltd. ยท Tests: MRG003 + Pucotenlimab, Gemcitabine, Docetaxel, or Capecitabine MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC NCT07331428Phase 21 site๐Ÿ“ Fuzhou Fujian Cancer Hospital ยท Tests: MRG003, Tislelizumab, Capecitabine Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma NCT06755567n/a1 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: MRI-based radiomics-clinical model Registry Platform Gastric/Esophageal Cancer (SAPHIR) NCT04290806n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG ยท Tests: Routine care as per site standard VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer NCT04057209NA4 sites๐Ÿ“ Paris๐Ÿ“ Mumbai๐Ÿ“ Bern Olgun Elicin ยท Tests: Single Vocal Cord Irradiation (SVCI), Arm A: Transoral CO2-Laser Microsurgical Cordectomy (TLM) Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors NCT07360314Phase 19 sites๐Ÿ“ New Haven๐Ÿ“ Huntersville๐Ÿ“ Galveston EMD Serono Research & Development Institute, Inc. ยท Tests: M7437, M7437 A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma NCT06753747Phase 1, Phase 21 site๐Ÿ“ Chengdu West China Hospital ยท Tests: Palbociclib, Afatinib(30mg), Afatinib(40mg), Afatinib(RP2D) Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study NCT07437898Phase 21 site๐Ÿ“ Putian The Affiliated Hospital of Putian University ยท Tests: Adebrelimab, chemotherapy Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome NCT06380686n/a2 sites๐Ÿ“ Essen๐Ÿ“ Hanover AIO-Studien-gGmbH ยท Tests: data collection Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma NCT07595770Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: โ€ข Adebrelimab and nab-paclitaxel, carboplatin in Combination With radiotherapy Improved Oral Health in Head and Neck Cancer Survivors NCT07173270NA1 site๐Ÿ“ Uppsala Uppsala University ยท Tests: Oral health support Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel NCT06947668n/a1 site๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients NCT02139020n/a5 sites๐Ÿ“ Ottignies๐Ÿ“ Charleroi๐Ÿ“ Haine-Saint-Paul Cliniques universitaires Saint-Luc- Universitรฉ Catholique dโ€ฆ ยท Tests: Plasma samples
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy